181
report
Next Generation Prevention - A Giving Smarter Guide
Precision health focuses on improving overall health and preventing disease, rather than treating d
isease.
+ Read More
report
Colorectal Cancer - A Giving Smarter Guide
The second deadliest of cancers when the incidents in both men and women are combined. Colorectal c
ancer refers to cancer that originates from either the colon or rectum.
+ Read More
report
Glioblastoma Multiforme: A Giving Smarter Guide to Accelerating Research Progress
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the b
rain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe.
+ Read More
report
Chronic Myelomonocytic Leukemia - A Giving Smarter Guide
Poor treatment options. No Cure. Patients and families affected by chronic myelomonocytic leukemia
(CMML) face many challenges and critical unmet needs, issues mirrored by the current state of the disease’s research.
+ Read More
report
Inflammatory Bowel Disease - A Giving Smarter Guide
Inflammatory bowel disease (IBD) is a collection of diseases including Crohn’s Disease and Ulcerati
ve Colitis, which result in chronic inflammation and damage along the lining and tissues of the digestive tract.
+ Read More
report
Neurofibromatosis Type 1 - A Giving Smarter Guide
With no effective therapies and no cure, Neurofibromatosis Type 1 (NF1) is a genetic disease t
hat can cause a broad range of abnormalities all throughout the body.
+ Read More
report
Small Cell Lung Cancer - A Giving Smarter Guide
Lung cancer has been one of the deadliest cancers in the United States. There are a number of chall
enges and unmet needs that act as barriers to desperately needed progress in small cell lung cancer (SCLC) research.
+ Read More
report
Parkinson's Disease - A Giving Smarter Guide
More than 1 million American lives are affected by Parkinson’s Disease (PD), a chronic, neurodegene
rative movement disorder. Mainly affecting the elderly, the cause of PD is unknown.
+ Read More
report
2023 Request for Proposals: Misophonia Research Fund
The Misophonia Research Fund (MRF) and the Milken Institute have partnered for the past four y
ears to advance a world where misophonia is scientifically understood and effective treatments are avail
+ Read More
report
Consensus Definition of Misophonia A Delphi Study
Misophonia was named and described in the early 2000’s (Jastreboff and Jastreboff, 2001, 2002) and
has since gained scientific recognition and clinical identification across a wide variety of disciplines (e.g., audiology, neuroscience, occupational ther
+ Read More
report
Clinical Developments in Follicular Lymphoma
Follicular lymphoma (FL) is a rare, slow-growing cancer that affects certain blood cells. People ex
periencing this form of non-Hodgkin lymphoma face multiple relapses over the course of their disease, which can run for years and sometimes decades.
+ Read More
report
Request for Proposals: Ann Theodore Foundation Breakthrough Sarcoidosis Initiative
Third Round of Funding Available for Sarcoidosis Research
The Ann Theodore Foundation, in partners
hip with MI Philanthropy, launched The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) in 2021, a grant program focused on
+ Read More